Tumor panel screens using 2D cell culture assays performed with well characterized, low passage PDX-derived and/or publicly available cell lines can be executed with predefined standard panels or using customized tumor panels.

These panel screens represent time- and cost-effective tools in the earliest stages of research to characterize developmental compounds for anti-cancer efficacy and selectivity to determine candidate tumor models for subsequent in vivo studies, or to support biomarker identification via bioinformatics approaches. Download our data, and contact us to discuss your project or with any questions you may have at 1.877.CRIVER.1(1.877.274.8371).